Felix Ehrat to ‘take personal responsibility’ for agreement with Michael Cohen
Federal and local authorities ‘in contact’ over possible concern at payments
Unregistered consultants play growing role in business of accessing the powerful
The opioid crisis warns of a need to look beyond drug companies’ sales volumes
Telecom group’s top in-house lobbyist forced out after employing Michael Cohen
AT&T and Korea Aerospace also say money to Cohen was for legitimate consulting
Arrangement reached after president vowed to block company’s takeover of Time Warner
AT&T, Novartis and firm linked to Russian oligarch are said to have provided funds
The control premium for AveXis is hefty, but should be given the benefit of the doubt
Deal is latest strategic move by Swiss drugmaker’s new chief executive
Swiss group focuses on pharma as $13bn deal hands UK partner control of consumer unit
Novartis deal strengthens UK group’s bet on consumer health and clears up uncertainty
Swiss group’s new chief sheds health business to focus on pharmaceuticals
Move to shed consumer health unit by Swiss group’s new CEO aims at focusing business
Scientists are focusing on new trials that will be an important test of the ‘amyloid plaque’ hypothesis
Prosecutor report names 10 as having accepted bribes from Novartis
Ann Aerts, drugmaker deal frenzy, India’s ‘menstrual man’
International Edition